What is the appropriate evaluation and management for a well‑appearing infant with purpuric lesions on the face and extremities and a platelet count of 90 × 10⁹/L?

Evaluation and Management of Well-Appearing Infant with Purpura and Platelet Count 90 × 10⁹/L

In a well-appearing infant with purpuric lesions on the face and extremities and a platelet count of 90 × 10⁹/L, observation without treatment is recommended, as this platelet count poses minimal bleeding risk and the infant has no signs of significant hemorrhage. 1

Initial Assessment Framework

Confirm True Thrombocytopenia

• Exclude pseudothrombocytopenia by repeating the platelet count in a heparin or sodium citrate tube 2
• Review the complete blood count for other cytopenias or abnormalities beyond isolated thrombocytopenia

Determine if This is Immune Thrombocytopenia (ITP)

Key diagnostic features:

• Isolated thrombocytopenia without other CBC abnormalities (except possible microcytic anemia from blood loss) 3
• No lymphadenopathy or hepatosplenomegaly on exam 3
• Well-appearing infant with only skin manifestations 1

Bone marrow examination is NOT necessary in children presenting with typical features of ITP 3. The 2011 and 2019 ASH guidelines explicitly moved away from routine bone marrow examination in pediatric ITP with classic presentation.

Alternative Diagnosis: Acute Hemorrhagic Edema of Infancy (AHEI)

If the purpura is:

• Large, palpable, targetoid purpuric lesions
• Localized to face and lower extremities (particularly bilateral lower limbs)
• Associated with recent viral illness or vaccination
• With normal or elevated platelet count

This suggests AHEI rather than ITP 4, 5, 6. AHEI is a benign, self-limiting leukocytoclastic vasculitis that resolves spontaneously in 1-3 weeks without treatment 5, 7.

Management Based on Platelet Count and Bleeding

For Platelet Count 90 × 10⁹/L (This Patient)

No treatment is indicated. The ASH 2019 guidelines provide clear thresholds:

• Observation alone is recommended for children with no bleeding or only minor bleeding (skin manifestations like petechiae and purpura), regardless of platelet count 1
• Platelet counts >50 × 10⁹/L are generally asymptomatic 2
• Risk of intracranial hemorrhage is extremely low (0.17-0.2%) even in children with platelets ≥20 × 10⁹/L 3

Treatment Thresholds

Treatment is only indicated for:

• Non-life-threatening mucosal bleeding (epistaxis lasting >15 minutes, oral bleeding) 3, 1
• Diminished health-related quality of life 1

If treatment becomes necessary:

• First-line: Short course corticosteroids (≤7 days) - either dexamethasone 0.6 mg/kg/day (max 40 mg) × 4 days OR prednisone 2-4 mg/kg/day (max 120 mg) × 5-7 days 1
• Alternative: IVIG (though observation is preferred over IVIG for minor bleeding - strong recommendation) 1
• Corticosteroids are preferred over anti-D immunoglobulin 1

Outpatient vs Inpatient Management

This infant should be managed as an outpatient with close follow-up 1. The 2019 ASH guidelines suggest against hospital admission for children with:

• Platelet count ≥20 × 10⁹/L
• No or mild bleeding (skin manifestations only)

Exceptions requiring admission:

• Uncertainty about diagnosis
• Social concerns or inability to guarantee follow-up
• Lives far from hospital 1

Follow-Up Plan

Ensure hematology follow-up within 24-72 hours of diagnosis (good practice statement) 1

Observation Period

• Well infants with localized purpura/petechiae can be observed for 4 hours to assess for progression 4
• If no progression of signs, safe discharge is appropriate 4
• 92% of well infants with purpura have localized lower limb involvement, often bilateral 4

Activity Restrictions

• No specific restrictions needed at platelet count 90 × 10⁹/L
• Activity restrictions to avoid trauma are only recommended when platelets <50 × 10⁹/L 2

Common Pitfalls to Avoid

1. Over-investigation: Do not routinely test for antinuclear antibodies in children with suspected ITP 3
2. Over-treatment: 75-80% of children enter remission by 6 months without treatment 3
3. Unnecessary bone marrow examination: Not indicated in typical ITP presentation 3
4. Treating based on platelet count alone: Treatment decisions should be based on bleeding symptoms, not arbitrary platelet thresholds 3
5. Missing AHEI: If purpura is palpable, targetoid, and follows viral illness with normal/elevated platelets, this is likely benign AHEI requiring only supportive care 4, 5

Prognosis

Natural history studies show excellent outcomes with observation:

• No episodes of intracranial hemorrhage or life-threatening bleeding in children with platelets ≥30 × 10⁹/L followed for 6 months 3
• In one study, only 2 of 26 children with platelets ≥20 × 10⁹/L required intervention during 5-32 months follow-up 3